International Biotechnology Trust as of Dec. 31, 2019
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 63 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | 7.4 | $20M | 93k | 218.84 | |
| Gilead Sciences (GILD) | 6.9 | $19M | 293k | 64.97 | |
| Amgen (AMGN) | 5.7 | $16M | 66k | 240.89 | |
| ACADIA Pharmaceuticals (ACAD) | 5.2 | $14M | 336k | 42.77 | |
| Neurocrine Biosciences (NBIX) | 5.2 | $14M | 133k | 107.44 | |
| Horizon Therapeutics | 5.1 | $14M | 390k | 36.19 | |
| Biogen Idec (BIIB) | 4.9 | $14M | 46k | 296.54 | |
| Regeneron Pharmaceuticals (REGN) | 3.9 | $11M | 29k | 375.48 | |
| D Stemline Therapeutics | 3.7 | $10M | 965k | 10.62 | |
| Alexion Pharmaceuticals | 3.4 | $9.3M | 86k | 108.08 | |
| BioMarin Pharmaceutical (BMRN) | 3.2 | $8.8M | 104k | 84.52 | |
| Illumina (ILMN) | 3.0 | $8.3M | 25k | 331.59 | |
| Amarin Corporation (AMRN) | 3.0 | $8.3M | 388k | 21.43 | |
| Merck & Co (MRK) | 2.7 | $7.5M | 83k | 90.92 | |
| Seattle Genetics | 2.6 | $7.3M | 64k | 114.23 | |
| Incyte Corporation (INCY) | 2.0 | $5.6M | 64k | 87.28 | |
| Ptc Therapeutics I (PTCT) | 2.0 | $5.5M | 114k | 47.98 | |
| Halozyme Therapeutics (HALO) | 2.0 | $5.5M | 308k | 17.73 | |
| Sarepta Therapeutics (SRPT) | 1.9 | $5.2M | 40k | 129.00 | |
| Alnylam Pharmaceuticals (ALNY) | 1.8 | $5.0M | 43k | 115.17 | |
| Kalvista Pharmaceuticals (KALV) | 1.8 | $4.9M | 277k | 17.75 | |
| Mirati Therapeutics | 1.7 | $4.6M | 36k | 128.97 | |
| Ionis Pharmaceuticals (IONS) | 1.2 | $3.2M | 54k | 60.36 | |
| Nektar Therapeutics (NKTR) | 1.1 | $3.0M | 140k | 21.58 | |
| Acceleron Pharma | 1.1 | $3.0M | 57k | 53.00 | |
| Novocure Ltd ord (NVCR) | 1.1 | $3.0M | 36k | 84.25 | |
| Sage Therapeutics (SAGE) | 1.1 | $3.0M | 41k | 72.05 | |
| Sangamo Biosciences (SGMO) | 0.9 | $2.5M | 303k | 8.36 | |
| Beigene (BGNE) | 0.8 | $2.3M | 14k | 165.79 | |
| Zogenix | 0.8 | $2.2M | 43k | 52.06 | |
| Myokardia | 0.8 | $2.2M | 30k | 72.87 | |
| Turning Point Therapeutics I | 0.8 | $2.2M | 35k | 62.26 | |
| Ascendis Pharma A S (ASND) | 0.7 | $1.9M | 14k | 138.99 | |
| Global Blood Therapeutics In | 0.7 | $1.8M | 23k | 79.48 | |
| Exelixis (EXEL) | 0.7 | $1.8M | 104k | 17.62 | |
| Esperion Therapeutics (ESPR) | 0.6 | $1.8M | 30k | 59.57 | |
| Agios Pharmaceuticals (AGIO) | 0.6 | $1.7M | 37k | 47.75 | |
| Momenta Pharmaceuticals | 0.6 | $1.6M | 80k | 19.69 | |
| Sutro Biopharma (STRO) | 0.6 | $1.5M | 139k | 10.97 | |
| Bluebird Bio (BLUE) | 0.5 | $1.5M | 17k | 87.71 | |
| Globus Med Inc cl a (GMED) | 0.5 | $1.4M | 24k | 58.88 | |
| Tricida | 0.5 | $1.4M | 37k | 37.65 | |
| Blueprint Medicines (BPMC) | 0.5 | $1.4M | 17k | 80.12 | |
| Crispr Therapeutics (CRSP) | 0.5 | $1.3M | 22k | 60.91 | |
| Millendo Therapeutics | 0.4 | $1.2M | 178k | 6.70 | |
| Gw Pharmaceuticals Plc ads | 0.4 | $1.1M | 10k | 104.51 | |
| Deciphera Pharmaceuticals (DCPH) | 0.4 | $1.1M | 17k | 62.18 | |
| EXACT Sciences Corporation (EXAS) | 0.4 | $989k | 11k | 92.43 | |
| Uniqure Nv (QURE) | 0.3 | $967k | 14k | 71.63 | |
| Amicus Therapeutics (FOLD) | 0.3 | $920k | 95k | 9.73 | |
| Inflarx Nv (IFRX) | 0.3 | $869k | 220k | 3.95 | |
| Fibrogen (FGEN) | 0.3 | $845k | 20k | 42.89 | |
| Insmed (INSM) | 0.3 | $801k | 34k | 23.84 | |
| Arena Pharmaceuticals | 0.3 | $749k | 17k | 45.39 | |
| Myriad Genetics (MYGN) | 0.2 | $680k | 25k | 27.20 | |
| Akcea Therapeutics Inc equities | 0.2 | $536k | 32k | 16.90 | |
| Supernus Pharmaceuticals (SUPN) | 0.2 | $473k | 20k | 23.71 | |
| Dermira | 0.2 | $454k | 30k | 15.13 | |
| Morphosys (MOR) | 0.1 | $402k | 11k | 35.59 | |
| Radius Health | 0.1 | $342k | 17k | 20.12 | |
| G1 Therapeutics (GTHX) | 0.1 | $296k | 11k | 26.43 | |
| Zealand Pharma A/s- | 0.1 | $188k | 5.7k | 33.26 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $163k | 10k | 16.30 |
